New schizophrenia drug satisfaction study recruits 300 patients

NCT ID NCT07101094

Recruiting now Disease control Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times

Summary

This study is tracking 300 adults with schizophrenia in the U.S. who are prescribed a new drug called xanomeline and trospium chloride (X/T). Researchers want to know if patients prefer this drug over their previous treatment and how satisfied they are with it. The study will also look at dosing, side effects, and why some people stop taking the medication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: xanomeline and trospium chloride (X/T) therapy
What this could lead to: If successful, this study could show that people with schizophrenia prefer and are more satisfied with this new drug combination, potentially leading to better treatment adherence and quality of life.
What could go wrong: This is an observational registry, not a controlled trial, so it cannot prove the drug works better than others. Results depend on real-world prescribing and patient reporting, which may be biased or incomplete.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SCHIZOPHRENIA

Contacts and locations

Locations

Boston Medical Center
RECRUITING

Boston, Massachusetts, 02118, United States
C-Trilogy Outreach
RECRUITING

Longview, Texas, 75601, United States
Continuum Health Providers
RECRUITING

Fort Mill, South Carolina, 29708, United States
Evanston Hospital
RECRUITING

Evanston, Illinois, 60201, United States
Hackensack Meridian Health - Carrier Clinic
RECRUITING

Belle Mead, New Jersey, 08502, United States
Haracec Clinical Research
RECRUITING

El Paso, Texas, 79902, United States
Local Institution - 0004
WITHDRAWN

Catonsville, Maryland, 21228, United States
Local Institution - 0008
NOT_YET_RECRUITING

Belmont, Massachusetts, 02478-1064, United States
Local Institution - 0009
NOT_YET_RECRUITING

Orange, California, 92868, United States
Local Institution - 0017
NOT_YET_RECRUITING

Bel Air, Maryland, 21015, United States
Lumos Clinical Research Center
RECRUITING

San Jose, California, 95124, United States
Mayflower Clinical
RECRUITING

South Dartmouth, Massachusetts, 02747, United States
New Dawn Psychiatric Services, PLLC
RECRUITING

Kinston, North Carolina, 28501, United States
New Dimension Group
RECRUITING

Rose Hill, North Carolina, 28458, United States
Omaha Insomnia and Psychiatric Services
RECRUITING

Omaha, Nebraska, 68144, United States
Radial - Manhattan
RECRUITING

New York, New York, 10018, United States
The Johns Hopkins Hospital
RECRUITING

Baltimore, Maryland, 21287, United States
Westlake Brain Health
RECRUITING

Westlake, Ohio, 44145, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.